Swiss National Bank Black Diamond Therapeutics, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$5.18 - $8.48 $246,568 - $403,648	-47,600 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$12.19 - $28.17 $282,808 - $653,544	23,200 Added 95.08%	47,600 $580,000
Q4 2020 Feb 05, 2021	BUY	$29.47 - $35.0 $129,668 - $154,000	4,400 Added 22.0%	24,400 $782,000
Q2 2020 Aug 05, 2020	BUY	$22.3 - $44.8 $446,000 - $896,000	20,000 New	20,000 $843,000

114

48.8M

1.8M

1.86M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $99.6M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.